Alpine Woods Capital Investors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $200K | Sell |
684
-3,388
| -83% | -$1.11M | 0.05% | 197 |
|
|
2025
Q4 | $1.43M | Sell |
4,072
-795
| -16% | -$269K | 0.34% | 79 |
|
|
2025
Q3 | $1.57M | Hold |
4,867
| – | – | 0.37% | 78 |
|
|
2025
Q2 | $1.89M | Sell |
4,867
-215
| -4% | -$86.5K | 0.45% | 71 |
|
|
2025
Q1 | $2.21M | Sell |
5,082
-750
| -13% | -$301K | 0.55% | 66 |
|
|
2024
Q4 | $2.15M | Buy |
5,832
+750
| +15% | +$314K | 0.41% | 76 |
|
|
2024
Q3 | $2.16M | Sell |
5,082
-10
| -0.2% | -$5.34K | 0.38% | 82 |
|
|
2024
Q2 | $2.76M | Hold |
5,092
| – | – | 0.43% | 76 |
|
|
2024
Q1 | $2.69M | Sell |
5,092
-7,910
| -61% | -$3.93M | 0.53% | 63 |
|
|
2023
Q4 | $6.13M | Hold |
13,002
| – | – | 0.92% | 41 |
|
|
2023
Q3 | $5.66M | Sell |
13,002
-100
| -0.8% | -$45.4K | 0.91% | 44 |
|
|
2023
Q2 | $5.82M | Sell |
13,102
-3,157
| -19% | -$1.46M | 0.91% | 42 |
|
|
2023
Q1 | $7.48M | Sell |
16,259
-5
| -0% | -$2.38K | 1.13% | 27 |
|
|
2022
Q4 | $8.34M | Hold |
16,264
| – | – | 1.22% | 28 |
|
|
2022
Q3 | $7.39M | Sell |
16,264
-6
| -0% | -$2.87K | 1.01% | 34 |
|
|
2022
Q2 | $7.85M | Hold |
16,270
| – | – | 0.98% | 38 |
|
|
2022
Q1 | $7.99M | Sell |
16,270
-136
| -0.8% | -$62.2K | 0.84% | 43 |
|
|
2021
Q4 | $7.61M | Hold |
16,406
| – | – | 0.75% | 45 |
|
|
2021
Q3 | $6.12M | Sell |
16,406
-20
| -0.1% | -$7.6K | 0.65% | 58 |
|
|
2021
Q2 | $6.27M | Sell |
16,426
-14,294
| -47% | -$5.46M | 0.65% | 56 |
|
|
2021
Q1 | $11M | Sell |
30,720
-180
| -0.6% | -$57.9K | 1.22% | 17 |
|
|
2020
Q4 | $9.92M | Sell |
30,900
-5,200
| -14% | -$1.6M | 1.21% | 16 |
|
|
2020
Q3 | $9.7M | Sell |
36,100
-100
| -0.3% | -$26.9K | 1.47% | 10 |
|
|
2020
Q2 | $9.52M | Sell |
36,200
-100
| -0.3% | -$26.7K | 1.83% | 9 |
|
|
2020
Q1 | $8.24M | Sell |
36,300
-100
| -0.3% | -$27.3K | 1.83% | 9 |
|
|
2019
Q4 | $11M | Hold |
36,400
| – | – | 2.09% | 9 |
|
|
2019
Q3 | $8.74M | Hold |
36,400
| – | – | 1.61% | 11 |
|
|
2019
Q2 | $10.3M | Buy |
36,400
+100
| +0.3% | +$27.3K | 2.13% | 9 |
|
|
2019
Q1 | $10.4M | Sell |
36,300
-100
| -0.3% | -$28.9K | 2.27% | 9 |
|
|
2018
Q4 | $9.56M | Hold |
36,400
| – | – | 2.29% | 8 |
|
|
2018
Q3 | $9.97M | Hold |
36,400
| – | – | 2.05% | 9 |
|
|
2018
Q2 | $8.66M | Sell |
36,400
-450
| -1% | -$104K | 1.89% | 9 |
|
|
2018
Q1 | $8.1M | Sell |
36,850
-27
| -0.1% | -$6.34K | 0.43% | 89 |
|
|
2017
Q4 | $8.3M | Hold |
36,877
| – | – | 0.41% | 88 |
|
|
2017
Q3 | $7M | Hold |
36,877
| – | – | 0.36% | 100 |
|
|
2017
Q2 | $6.94M | Hold |
36,877
| – | – | 0.37% | 92 |
|
|
2017
Q1 | $6.1M | Hold |
36,877
| – | – | 0.32% | 102 |
|
|
2016
Q4 | $5.3M | Sell |
36,877
-35
| -0.1% | -$4.69K | 0.29% | 113 |
|
|
2016
Q3 | $4.63M | Sell |
36,912
-38
| -0.1% | -$4.91K | 0.26% | 113 |
|
|
2016
Q2 | $4.85M | Sell |
36,950
-100
| -0.3% | -$13.7K | 0.29% | 105 |
|
|
2016
Q1 | $5.15M | Sell |
37,050
-150
| -0.4% | -$20K | 0.3% | 109 |
|
|
2015
Q4 | $5.19M | Sell |
37,200
-70,000
| -65% | -$9.64M | 0.28% | 115 |
|
|
2015
Q3 | $15M | Buy |
107,200
+21,000
| +24% | +$3.16M | 0.82% | 39 |
|
|
2015
Q2 | $14.1M | Buy |
86,200
+49,300
| +134% | +$7.88M | 0.72% | 41 |
|
|
2015
Q1 | $5.7M | Hold |
36,900
| – | – | 0.29% | 100 |
|
|
2014
Q4 | $4.64M | Hold |
36,900
| – | – | 0.24% | 115 |
|
|
2014
Q3 | $4.41M | Sell |
36,900
-500
| -1% | -$57.4K | 0.23% | 113 |
|
|
2014
Q2 | $4.03K | Hold |
37,400
| – | – | 0.1% | 114 |
|
|
2014
Q1 | $3.72M | Hold |
37,400
| – | – | 0.21% | 114 |
|
|
2013
Q4 | $3.46M | Hold |
37,400
| – | – | 0.2% | 115 |
|
|
2013
Q3 | $3.13M | Hold |
37,400
| – | – | 0.19% | 110 |
|
|
2013
Q2 | $3.06M | Buy |
+37,400
| New | +$2.8M | 0.2% | 107 |
|
Other funds holding ELV
VCM
VPM
Alpine Woods Capital Investors's ELV Position: Q1 2026 in Review
Alpine Woods Capital Investors reduced its Elevance Health (ELV) stake by 83% in Q1 2026, selling an estimated $1.11M and leaving 684 shares worth $200K. The position accounts for 0.05% of the portfolio, ranked #197.
Alpine Woods Capital Investors first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $15M in Q3 2015. 1,465 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Alpine Woods Capital Investors held 684 shares of Elevance Health worth $200K as of Q1 2026.
- Alpine Woods Capital Investors sold 3,388 Elevance Health shares in Q1 2026, an estimated $1.11M.
- Elevance Health made up 0.05% of Alpine Woods Capital Investors's portfolio in Q1 2026, its #197 holding.
- Alpine Woods Capital Investors first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Alpine Woods Capital Investors's Elevance Health position peaked at $15M in Q3 2015.
- 1,465 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Alpine Woods Capital Investors's 13F filing for Q1 2026, filed 27 May 2026.